399 related articles for article (PubMed ID: 30876953)
1. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML
J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953
[TBL] [Abstract][Full Text] [Related]
2. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
[TBL] [Abstract][Full Text] [Related]
3. Brain-targeted co-delivery of β-amyloid converting enzyme 1 shRNA and epigallocatechin-3-gallate by multifunctional nanocarriers for Alzheimer's disease treatment.
Lv L; Yang F; Li H; Yuan J
IUBMB Life; 2020 Aug; 72(8):1819-1829. PubMed ID: 32668504
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.
Ettcheto M; Cano A; Manzine PR; Busquets O; Verdaguer E; Castro-Torres RD; García ML; Beas-Zarate C; Olloquequi J; Auladell C; Folch J; Camins A
Mol Neurobiol; 2020 Apr; 57(4):1814-1827. PubMed ID: 31838720
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer's disease in a rat/mouse model: a systematic review.
Khalifa MKA; Abdel-Sattar SA; Amin OM; Kohaf NA; Zaky HS; Abd El-Fattah MA; Mohammed KHA; Badawi NM; Mansoor I; Eassa HA
Daru; 2024 Jun; 32(1):319-337. PubMed ID: 38079104
[TBL] [Abstract][Full Text] [Related]
6. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate PEGylated poly(lactic-co-glycolic) acid nanoparticles mitigate striatal pathology and motor deficits in 3-nitropropionic acid intoxicated mice.
Cano A; Ettcheto M; Espina M; Auladell C; Folch J; Kühne BA; Barenys M; Sánchez-López E; Souto EB; García ML; Turowski P; Camins A
Nanomedicine (Lond); 2021 Jan; 16(1):19-35. PubMed ID: 33410329
[No Abstract] [Full Text] [Related]
8. PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies.
Silva-Abreu M; Calpena AC; Andrés-Benito P; Aso E; Romero IA; Roig-Carles D; Gromnicova R; Espina M; Ferrer I; García ML; Male D
Int J Nanomedicine; 2018; 13():5577-5590. PubMed ID: 30271148
[TBL] [Abstract][Full Text] [Related]
9. [Constructing Brain Aβ-Targeting Nanoparticles Loaded with EGCG for Treating Alzheimer's Disease in Mice].
Yang P; Guo Q; Xu ST; Sheng DY; Zhang QZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):605-611. PubMed ID: 34323038
[TBL] [Abstract][Full Text] [Related]
10. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy.
Cano A; Ettcheto M; Espina M; Auladell C; Calpena AC; Folch J; Barenys M; Sánchez-López E; Camins A; García ML
Nanomedicine; 2018 Jun; 14(4):1073-1085. PubMed ID: 29454994
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage.
Srivastava AK; Bhatnagar P; Singh M; Mishra S; Kumar P; Shukla Y; Gupta KC
Int J Nanomedicine; 2013; 8():1451-62. PubMed ID: 23717041
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice.
Mori T; Koyama N; Tan J; Segawa T; Maeda M; Town T
J Biol Chem; 2019 Feb; 294(8):2714-2731. PubMed ID: 30563837
[TBL] [Abstract][Full Text] [Related]
14. PEGylated-liposomal astaxanthin ameliorates Aβ neurotoxicity and Alzheimer-related phenotypes by scavenging formaldehyde.
Gu Z; Zhao H; Song Y; Kou Y; Yang W; Li Y; Li X; Ding L; Sun Z; Lin J; Wang Q; Li X; Yang X; Huang X; Yang C; Tong Z
J Control Release; 2024 Feb; 366():783-797. PubMed ID: 38242211
[TBL] [Abstract][Full Text] [Related]
15.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.
Zhang L; Chen W; Tu G; Chen X; Lu Y; Wu L; Zheng D
Int J Nanomedicine; 2020; 15():4417-4429. PubMed ID: 32606686
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats.
Zhang G; Zhang J
Drug Des Devel Ther; 2018; 12():2509-2518. PubMed ID: 30147298
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
Jia N; Han K; Kong JJ; Zhang XM; Sha S; Ren GR; Cao YP
Mol Cell Biochem; 2013 Aug; 380(1-2):211-8. PubMed ID: 23660953
[TBL] [Abstract][Full Text] [Related]
19. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.
Dube A; Nicolazzo JA; Larson I
Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
